Transcriptomics-based screening identifies pharmacological inhibition of Hsp90 as a means to defer aging
G. E. Janssens, X.-X. Lin, L. Millan-Arino, R. I. Seinstra, N. Stroustrup, E. A. A. Nollen, C. G. Riedel
The paper uses transcriptomics to screen for aging-deferring compounds, identifying Hsp90 inhibitors as potential geroprotectors.
bioRxiv · Nov 14, 2018Cell Biology